DEA insists cold drug is not meth-resistant

September 10, 2013 by Jim Salter

A cold and allergy decongestant containing what the manufacturer says is the first pseudoephedrine that cannot be used in meth production is now available nationwide.

The Drug Enforcement Administration refuses to allow Zephrex-D to be sold over the counter, saying government chemists were able to manufacture from the product.

Zephrex-D has been sold in Missouri since December and suburban St. Louis company Westport Pharmaceuticals rolled out the product to 15,000 pharmacies nationwide last month.

Westport says the amount of meth that can be made using Zephrex-D is so small that it's impractical for meth-makers. The Missouri Narcotics Officers Association says it hasn't found the product in any meth labs.

Nonetheless, the DEA insisted Tuesday that Zephrex-D must be sold from behind the counter like all other products.

Explore further: DEA disagrees with firm's meth-resistant claims

Related Stories

DEA disagrees with firm's meth-resistant claims

May 29, 2013
The Drug Enforcement Administration says a suburban St. Louis pharmaceutical company is wrong for marketing its pseudoephedrine product to imply methamphetamine cannot be made with it.

Methamphetamine use increasing again, researchers find

January 25, 2012
(Medical Xpress) -- Use of methamphetamines is on the rise nationally after a decrease a few years ago, according to university researchers.

Child abuse and foster care admissions increase when parents use methamphetamines

July 2, 2012
Methamphetamine abuse leads to an increase in child abuse and neglect, which causes an increase in foster care admissions, according to a study from Baylor University.

Recommended for you

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.